| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 16 | / | 2022 | ||||||||
| Date of issue: | 2022-07-21 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| 2022 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 136 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the 2022 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto. The report will be published on the Company's website (www.krka.biz) from 21 July 2022 onwards, for a period of at least 10 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| The Krka Group and Krka Company Unaudited Semi Annual Report 2022.pdf | The Krka group and Company Unaudited Semi Annual Report 2022 | ||||||||||
| Press Release.pdf | Press Release | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2022-07-21 | Jože Colarič | President of the Management Board and CEO | |||
The Krka Group and Krka Company Unaudited Semi Annual Report 2022.pdf
Press Release.pdf
